Concepedia

Publication | Closed Access

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.

DOI

401

Citations

0

References

1996

Year

Mark Kaminski, Kenneth Zasadny, Isaac R. Francis, Matthias Fenner, C. W. Ross, Adam W. Milik, Judith Estes, Melissa Tuck, Denise Regan, Susan J. Fisher,
Journal of Clinical Oncology

Abstract

Nonmyeloablative radioimmunotherapy with 131I-anti-B1 is associated with a high rate of durable remissions in patients with B-cell lymphoma refractory to chemotherapy.